Know Cancer

or
forgot password

Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment


N/A
18 Years
70 Years
Not Enrolling
Both
Hepatocellular Carcinoma

Thank you

Trial Information

Role of Procalcitonin in Differantiation Between Bacerial Infection and Non Infectious Inflammation in Febrile Hepatocellular Carcinoma Patients After Locoregional Treatment


Inclusion Criteria:



1. - Hepatocellular carcinoma patients who will undergo TACE and/or radio-frequency.

2. - Fever more than 38C after 48 hours post intervention.

Exclusion Criteria:

1. HCC Patients who does not develop fever after intervention.

2. Proven infection elsewhere (e.g. UTI, chest infection..)

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

Differantiate between post- embolization syndrom and sepsis following locoregional treatment for hepatocellular carcinoma

Outcome Time Frame:

6months

Safety Issue:

Yes

Principal Investigator

Hisham K Dabbous, professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Tropical medicine department

Authority:

Egypt: Institutional Review Board

Study ID:

iman montasser

NCT ID:

NCT01518829

Start Date:

April 2012

Completion Date:

January 2013

Related Keywords:

  • Hepatocellular Carcinoma
  • hepatocellular carcinom
  • postablation syndrom
  • procalcitonin
  • Carcinoma
  • Carcinoma, Hepatocellular

Name

Location